The U.S. Department of Agriculture (USDA) released its preliminary report on August farm prices on Friday afternoon. The August all-products price index dropped by 12 points (6%) to 188 month-over-month, with the crop index down 7.4% and the livestock index down 1%. The preliminary all-products index is down 5% year-over-year. The index uses prices from 1990-1992 as its base value (100).
The USDA noted that increased sales of cattle, barley, and calves offset lower sales of wheat, corn, and soybeans.
Farm costs, measured by the prices paid index rose 1% month-over-month to 221, and that�� 5% higher than August of 2012. Higher prices for feeder cattle and LP gas, among other things, offset lower prices for nitrogen fertilizer, feed grains, and other fertilizers.
Prices received by farmers rose the most for commercial vegetables (up 13% from July) and fruits and nuts (up 1.6%). Oilseeds, cotton, feed grains and hay, and food grains were all lower month-over-month. Compared with August 2012, commercial vegetables prices are a whopping 30% higher than a year ago.
Hot Sliver Companies To Own For 2015: Cleveland BioLabs Inc.(CBLI)
Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultan eously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.
Advisors' Opinion:- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) shares tumbled 34.67% to touch a new 52-week low of $0.74 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
Top 5 Industrial Disributor Companies To Watch For 2014: Builders FirstSource Inc.(BLDR)
Builders FirstSource, Inc. engages in the manufacture and supply of structural and related building products for residential new construction primarily in the southern and eastern United States. The company offers prefabricated components, including floor trusses, roof trusses, wall panels, stairs, and engineered wood; and window and door products, such as aluminum and vinyl windows, and pre-hung interior and exterior doors, as well as assembles and distributes interior and exterior door units. It also provides lumber and lumber sheet products comprising dimensional lumber, plywood, and oriented strand board products; millwork products, including interior trim, exterior trim, columns, and posts, as well as custom exterior featured products; and other building products, such as cabinets, gypsum, hardware, composite materials, roofing, and insulation. In addition, the company offers turn-key framing, shell construction, design assistance, and professional installation servic es for products spanning its product categories, as well as provides a range of construction services. It serves customers ranging from production homebuilders to small custom homebuilders. The company was formerly known as BSL Holdings, Inc. and changed its name to Builders FirstSource, Inc. in October 1999. Builders FirstSource, Inc. was founded in 1998 and is based in Dallas, Texas.
Advisors' Opinion:- [By Rex Moore]
The annual Value Investor Conference is one of the premier events surrounding Berkshire Hathaway's annual meeting in Omaha. The Motley Fool's Michael Olsen and Rex Moore were in attendance and talked to several value investors.�In today's video, Michael asks Bob Robotti, founder of Robotti & Co., about his investment in Builders FirstSource (NASDAQ: BLDR ) .
Top 5 Industrial Disributor Companies To Watch For 2014: Hickory Tech Corporation (HTCO)
Hickory Tech Corporation provides integrated communications services to business and residential customers in the Midwest. The company operates in two segments, Business Sector and Telecom Sector. The Business Sector segment offers integrated data services, such as fiber, data and Internet, voice and voice over Internet protocol, managed and hosted, data center, equipment, and total care support services. This segment also distributes telecommunications and data processing equipment, as well as provides network and equipment monitoring, maintenance, and equipment consulting services; and offers fiber-based transport for regional and national telecommunications carriers, wireless carriers, and other providers. It serves businesses primarily in the upper Midwest. The Telecom Sector segment offers network access services; and broadband services, such as residential and business DSL access, high-speed Internet, digital TV, and business Ethernet services. It also provides local telephone, long distance, and calling features services; and directory assistance, operator service, and long distance private lines. In addition, this segment offers directory publishing, customer premise equipment sales, bill processing, and add/move/change services. It owns and operates approximately 900 mile fiber optic network and facilities in Minnesota. Hickory Tech Corporation was founded in 1898 and is headquartered in Mankato, Minnesota.
Advisors' Opinion:- [By Marc Bastow]
Hickory Tech (HTCO), a communications provider in several Midwest states, announced a 3% dividend increase to 15 cents per share, payable Dec. 5 to shareholders of record as of Nov. 15.
HTCO Dividend Yield: 5.5%
Top 5 Industrial Disributor Companies To Watch For 2014: Infinity Pharmaceuticals Inc.(INFI)
Infinity Pharmaceuticals, Inc. engages in the discovery and development of medicines for difficult-to-treat diseases. The company?s lead product candidates include saridegib (IPI-926), an oral molecule with the potential to treat a range of cancers by disrupting malignant activation of the Hedgehog pathway; and Retaspimycin HCl (IPI-504), a heat shock protein 90 (Hsp90) inhibitor. Its Saridegib is in a Phase II clinical trial for the treatment of metastatic or inoperable chondrosarcoma and a Phase II exploratory trial in patients with myelofibrosis. The company?s Retaspimycin HCl is in a Phase II trial in combination with docetaxel to treat patients with non-small cell lung cancer (NSCLC); and in a Phase Ib/II trial in combination with everolimus, known as Afinitor, in approximately 45 NSCLC patients with a KRAS mutation. Its pipeline also includes IPI-145, an inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) in Phase I development to treat in flammation and hematologic malignancies. Infinity Pharmaceuticals has a strategic alliance with Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Limited to develop and commercialize pharmaceutical products; and a development and license agreement with Millennium to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K, including IPI-145. Purdue Pharmaceutical Products is planning to conduct Phase II studies of IPI-940 in pain. The company is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
- [By Keith Speights]
No win for the spin
Another biotech, Infinity Pharmaceuticals (NASDAQ: INFI ) , also announced clinical results this week. The company's press release trumpeted "encouraging" findings for its experimental leukemia drug. Mr. Market didn't appear to buy the spin. Infinity shares tanked nearly 33% for the week. - [By Ben Levisohn]
Knapp and Slover were also kind enough to provide a screen of stocks that could outperform. They started with the Russell 2000, removed the smallest 40% based on market cap (the aforementioned liquidity issues), then selected the 5% worst performers from among the 30% cheapest stocks based on book-to-price. The result is a bunch of names you never heard of, including Infinity Pharmaceuticals (INFI), Fusion-IO (FIO), Walter Energy (WLT), Hecla Mining (HL) and Molycorp�(MCP).
- [By Bryan Murphy]
When investors think of non-Hodgkin's lymphoma stocks, big names like Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) come to mind. Both GILD and CELG are making prolific progress in the war on NHL, and both are fine, well-positioned companies. It's little Infinity Pharmaceuticals Inc. (NASDAQ:INFI) that may end up making the proverbial quantum leap in the non-Hodgkin's lymphoma stocks arena, however, and better still, it's INFI shares that may well end up doling out a much bigger reward than Gilead or Celgene could to newcomers.
No comments:
Post a Comment